SVA's Business Systems Expertise Benefits MyoKardia

myokardia-page-thumb
Project:

MyoKardia

Technology:

Commercialization Launch Readiness

Type:

Business Architecture, Systems Selection

Services:

Management and Business Consultations, Business Process Analysis and Systems Design

As MyoKardia neared the end of its first Phase III program we engaged SVA to evaluate the commercial capabilities of our finance systems. They took a highly collaborative approach, working with a cross-functional team across finance, supply chain, commercial and legal to develop an in-depth understanding of our existing capabilities and future needs. SVA was able to identify those processes that would need modification to scale up, as well as recommendations for modest enhancements to current systems, resulting in significant savings. We highly value our partnership with SVA; they adapted their approach to our situation and proposed practical solutions that met our needs.

Steve Ware, VP, Corporate Controller

THE STORY

Four scientific leaders who together, shared a vision that there was a lack of therapeutic innovation in treating cardiovascular diseases – the number one cause of death globally, founded MyoKardia in 2012. The firm is pioneering a precision medicine approach to treating cardiomyopathies and other forms of heart failure that result from biomechanical defects in cardiac muscle contraction.

MyoKardia engaged SVA Consulting at the end of its Phase 3 program to evaluate the commercial capabilities of their financial systems. The question at hand was whether MyoKardia should take on the implementation of a new ERP system, or whether their current ERP system would support a commercial company.

SVA considered both the views and perspectives of the stakeholders at MyoKardia as well as consulted on the business processes that would need to be implemented as the company transitioned into a commercially-operating company. SVA then compared the needs of the organization to the current business systems and recommended a fit-for-purpose approach to gaining the required business capabilities, leveraging and building from MyoKardia's current systems.

THE RESULTS

SVA provided a roadmap to leverage and optimize MyoKardia's existing business systems, gaining the functionality needed to operate a commercial company. Rather than taking on an expensive and resource-intensive implementation of a new ERP, SVA considered the current and likely future needs of the organization to facilitate both the decision to leverage the existing business systems as well as to identify what future business trigger points may cause the company to reconsider moving to a more extensive ERP.

Learn more about SVA Consulting technology services